Last reviewed · How we verify

NCT03111394

Study of myMS in Participants With a Diagnosis of Multiple Sclerosis

Completed Last updated 26 November 2021
What this trial tests

trial in Multiple Sclerosis in 200 participants. Completed in 25 November 2021.

Timeline
17 April 2017
Primary endpoint
25 November 2021
25 November 2021

Quick facts

Lead sponsorUniversity of Southern California
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date17 April 2017
Primary completion25 November 2021
Estimated completion25 November 2021
Sites1 location across United States

Conditions studied

Sponsor

University of Southern California

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study looking at the feasibility of a mobile application (app) to collect data from active tasks (questionnaires, 6Mapp™, COGapp™, VISapp™), clinical magnetic resonance imaging information and conduct genome-wide association studies in subjects with multiple sclerosis. Participants will be self-referred to this study from different sources; patient advocacy groups, social media tools, clinicaltrials.gov, and flyers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03111394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing